A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Sponsor
Korea United Pharm. Inc.
Study ID
NCT07682948
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
19 Years - 54 Years
Healthy Volunteers
Accepted

Interventions

  • Investigational Product 1 — DRUG
    UIC202601 1Tab/day for 7 days
  • Investigational Product 2 — DRUG
    UIC202602 1Tab/day for 7 days
  • Investigational Product 1 + Investigational Product 2 — DRUG
    UIC202601+UIC202602 2Tab/day for 7 days

Study Details

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Key Dates

First listed
Jul 6, 2026
Start date
Jul 1, 2026
Status verified
Jun 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
36 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Arm A
  • Experimental: Arm B

Primary Outcome Measure

AUCτ,ss [ Time Frame: 0 to 24hr ]

Find similar trials

Nationwide
Hypertension (high blood pressure) trialsCardiology trialsHeart disease trials

Related Studies